Annual Accounts Payable
$2.92 M
-$1.89 M-39.27%
December 31, 2023
Summary
- As of February 7, 2025, CTKB annual accounts payable is $2.92 million, with the most recent change of -$1.89 million (-39.27%) on December 31, 2023.
- During the last 3 years, CTKB annual accounts payable has fallen by -$26.00 thousand (-0.88%).
- CTKB annual accounts payable is now -39.27% below its all-time high of $4.80 million, reached on December 31, 2022.
Performance
CTKB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.39 M
+$2.20 M+68.88%
September 30, 2024
Summary
- As of February 7, 2025, CTKB quarterly accounts payable is $5.39 million, with the most recent change of +$2.20 million (+68.88%) on September 30, 2024.
- Over the past year, CTKB quarterly accounts payable has increased by +$678.00 thousand (+14.39%).
- CTKB quarterly accounts payable is now -20.15% below its all-time high of $6.75 million, reached on June 30, 2022.
Performance
CTKB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CTKB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.3% | +14.4% |
| 3 y3 years | -0.9% | +74.8% |
| 5 y5 years | +24.6% | +74.8% |
CTKB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.3% | at low | -20.1% | +77.7% |
| 5 y | 5-year | -39.3% | +24.6% | -20.1% | +83.0% |
| alltime | all time | -39.3% | +24.6% | -20.1% | +83.0% |
Cytek Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.39 M(+68.9%) |
| Jun 2024 | - | $3.19 M(-14.3%) |
| Mar 2024 | - | $3.73 M(+22.9%) |
| Dec 2023 | $2.92 M(-39.3%) | $3.03 M(-35.6%) |
| Sep 2023 | - | $4.71 M(+52.9%) |
| Jun 2023 | - | $3.08 M(-41.6%) |
| Mar 2023 | - | $5.28 M(+9.9%) |
| Dec 2022 | $4.80 M | $4.80 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.64 M(-16.4%) |
| Jun 2022 | - | $6.75 M(+13.0%) |
| Mar 2022 | - | $5.97 M(+96.8%) |
| Dec 2021 | $3.03 M(+3.1%) | $3.03 M(-22.7%) |
| Sep 2021 | - | $3.93 M(+18.1%) |
| Jun 2021 | - | $3.32 M(-1.1%) |
| Mar 2021 | - | $3.36 M(+14.2%) |
| Dec 2020 | $2.94 M(+25.7%) | $2.94 M |
| Dec 2019 | $2.34 M | - |
FAQ
- What is Cytek Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Cytek Biosciences?
- What is Cytek Biosciences annual accounts payable year-on-year change?
- What is Cytek Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cytek Biosciences?
- What is Cytek Biosciences quarterly accounts payable year-on-year change?
What is Cytek Biosciences annual accounts payable?
The current annual accounts payable of CTKB is $2.92 M
What is the all time high annual accounts payable for Cytek Biosciences?
Cytek Biosciences all-time high annual accounts payable is $4.80 M
What is Cytek Biosciences annual accounts payable year-on-year change?
Over the past year, CTKB annual accounts payable has changed by -$1.89 M (-39.27%)
What is Cytek Biosciences quarterly accounts payable?
The current quarterly accounts payable of CTKB is $5.39 M
What is the all time high quarterly accounts payable for Cytek Biosciences?
Cytek Biosciences all-time high quarterly accounts payable is $6.75 M
What is Cytek Biosciences quarterly accounts payable year-on-year change?
Over the past year, CTKB quarterly accounts payable has changed by +$678.00 K (+14.39%)